Canadian children still not getting enough vitamin D… cancer rates continue to climb Monday, February 18, 2019 by: Russel Davis Tags: badhealth , breast cancer , Canada , Canadians , cancer causes , children’s health , Colorectal Cancer , lung cancer , nutrients , Prostate cancer , supplements , vitamin D , vitamin deficiency ( Natural News ) Vitamin D levels among Canadian children did not show any improvement despite a 2010 revision in the country’s dietary guidelines recommending higher nutrient intake, a study revealed. As part of the study, the researchers pooled data from the Cycle 1 and Cycle 3 series of the Canadian Health Measure Survey , which were taken from …
CiteULike Link More than 95% of persons aged 50 years or older are latently infected with varicella-zoster virus and are at risk for symptomatic reactivation manifesting as herpes zoster (HZ); lifetime risk for this outcome is about 30%. Risk increases with age and is increased further by immunosuppression and a growing list of comorbid conditions, including diabetes mellitus, chronic kidney disease, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, and chronic obstructive pulmonary disease. Herpes zoster causes significant illness and health care costs, especially among those who develop postherpetic neuralgia. In 2006, the U.S. Food and Drug Administration (FDA …
More than 30 million Americans have diabetes, a chronic illness that affects the body’s ability to produce or use insulin and convert food into energy, according to the Centers for Disease Control and Prevention. Its prevalence has tripled in the U.S. over the past two decades and has become the seventh-leading cause of death, as well as the costliest illness in the country.
Despite rising prevalence of heart disease in China, primary preventive treatment rates remain low American College of Physicians
URLs go live when the embargo lifts
About one in 10 middle-aged adults in China are at high risk for cardiovascular disease (CVD), yet use of risk reduction therapies is strikingly low. Findings from a Chinese national screening project are published in Annals of Internal Medicine .
SALT LAKE CITY–( BUSINESS WIRE )–Foldax, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted IDE approval to begin an Early Feasibility Study of the Tria surgical aortic heart valve for the treatment of aortic valve disease.